Sihuan Pharmaceutical Holdings Group Ltd.

SEHK:460 株式レポート

時価総額:HK$5.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Sihuan Pharmaceutical Holdings Group マネジメント

マネジメント 基準チェック /34

Sihuan Pharmaceutical Holdings Group'sの CEO はWeicheng Guoで、 Oct2014年に任命され、 の在任期間は 9.67年です。 の年間総報酬はCN¥ 3.00Mで、 100%給与と0%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.12%を直接所有しており、その価値はHK$ 6.36M 。経営陣と取締役会の平均在任期間はそれぞれ1.7年と8.3年です。

主要情報

Weicheng Guo

最高経営責任者

CN¥3.0m

報酬総額

CEO給与比率100.0%
CEO在任期間9.8yrs
CEOの所有権0.1%
経営陣の平均在職期間1.8yrs
取締役会の平均在任期間8.3yrs

経営陣の近況

Here's Why It's Unlikely That Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO Will See A Pay Rise This Year

May 31
Here's Why It's Unlikely That Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO Will See A Pay Rise This Year

Recent updates

Here's Why It's Unlikely That Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO Will See A Pay Rise This Year

May 31
Here's Why It's Unlikely That Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO Will See A Pay Rise This Year

Investors Still Waiting For A Pull Back In Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

May 27
Investors Still Waiting For A Pull Back In Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Dec 05
A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Health Check: How Prudently Does Sihuan Pharmaceutical Holdings Group (HKG:460) Use Debt?

Oct 31
Health Check: How Prudently Does Sihuan Pharmaceutical Holdings Group (HKG:460) Use Debt?

Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Aug 19
Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Apr 21
Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Is Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Worth HK$0.8 Based On Its Intrinsic Value?

Nov 03
Is Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Worth HK$0.8 Based On Its Intrinsic Value?

Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?

Oct 11
Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?

Is There An Opportunity With Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) 34% Undervaluation?

Jun 21
Is There An Opportunity With Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) 34% Undervaluation?

Estimating The Intrinsic Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Mar 09
Estimating The Intrinsic Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Nov 28
A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Sihuan Pharmaceutical Holdings Group (HKG:460) Seems To Use Debt Rather Sparingly

Sep 26
Sihuan Pharmaceutical Holdings Group (HKG:460) Seems To Use Debt Rather Sparingly

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO For Now

Jun 22
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO For Now

How Does Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Fare As A Dividend Stock?

May 11
How Does Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Fare As A Dividend Stock?

Sihuan Pharmaceutical Holdings Group's (HKG:460) Shareholders May Want To Dig Deeper Than Statutory Profit

Mar 30
Sihuan Pharmaceutical Holdings Group's (HKG:460) Shareholders May Want To Dig Deeper Than Statutory Profit

How Much Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Do Insiders Own?

Mar 07
How Much Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Do Insiders Own?

Should You Buy Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) For Its Dividend?

Feb 07
Should You Buy Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) For Its Dividend?

Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Jan 11
Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)

Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?

Dec 21
Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?

Why Sihuan Pharmaceutical Holdings Group's (HKG:460) CEO Pay Matters

Dec 07
Why Sihuan Pharmaceutical Holdings Group's (HKG:460) CEO Pay Matters

CEO報酬分析

Sihuan Pharmaceutical Holdings Group の収益と比較して、Weicheng Guo の報酬はどのように変化したか?
日付総報酬給与会社業績
Dec 31 2023CN¥3mCN¥3m

-CN¥54m

Jun 30 2023n/an/a

-CN¥2b

Mar 31 2023n/an/a

-CN¥2b

Dec 31 2022CN¥3mCN¥3m

-CN¥2b

Jun 30 2022n/an/a

-CN¥144m

Mar 31 2022n/an/a

CN¥141m

Dec 31 2021CN¥6mCN¥6m

CN¥427m

Sep 30 2021n/an/a

CN¥681m

Jun 30 2021n/an/a

CN¥945m

Mar 31 2021n/an/a

CN¥727m

Dec 31 2020CN¥6mCN¥6m

CN¥508m

Sep 30 2020n/an/a

-CN¥14m

Jun 30 2020n/an/a

-CN¥537m

Mar 31 2020n/an/a

-CN¥2b

Dec 31 2019CN¥6mCN¥6m

-CN¥3b

Sep 30 2019n/an/a

-CN¥2b

Jun 30 2019n/an/a

-CN¥1b

Mar 31 2019n/an/a

CN¥238m

Dec 31 2018CN¥6mCN¥6m

CN¥2b

Sep 30 2018n/an/a

CN¥1b

Jun 30 2018n/an/a

CN¥1b

Mar 31 2018n/an/a

CN¥1b

Dec 31 2017CN¥6mCN¥6m

CN¥1b

報酬と市場: Weichengの 総報酬 ($USD 413.46K ) は、 Hong Kong市場 ($USD 464.36K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Weichengの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Weicheng Guo (60 yo)

9.8yrs

在職期間

CN¥3,000,000

報酬

Dr. Weicheng Guo co-founded Sihuan Pharmaceutical Holdings Group Ltd. and has been its Chief Executive Officer since October 20, 2014. Dr. Guo is responsible for the overall operations of Sihuan Pharmaceut...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Fengsheng Che
Co-Founder & Executive Chairman18.2yrsCN¥7.00m5.37%
CN¥ 278.6m
Weicheng Guo
Deputy Chairman & CEO9.8yrsCN¥3.00m0.12%
CN¥ 6.4m
Guili Miao
Deputy CEO1.8yrsCN¥5.05mデータなし
Jionglong Zhang
Executive Director3.7yrsCN¥646.00k2.15%
CN¥ 111.4m
Yanling Chen
Joint Company Secretary & Executive Director1.8yrsCN¥1.77mデータなし
Kin Wai Li
Joint Company Secretary1.8yrsデータなしデータなし
Xianhui Meng
Deputy General Managerno dataCN¥4.26mデータなし

1.8yrs

平均在職期間

60yo

平均年齢

経験豊富な経営陣: 460の経営陣は 経験豊富 とはみなされません ( 1.7年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Fengsheng Che
Co-Founder & Executive Chairman18.2yrsCN¥7.00m5.37%
CN¥ 278.6m
Weicheng Guo
Deputy Chairman & CEO18.2yrsCN¥3.00m0.12%
CN¥ 6.4m
Guili Miao
Deputy CEO1.8yrsCN¥5.05mデータなし
Jionglong Zhang
Executive Director6.3yrsCN¥646.00k2.15%
CN¥ 111.4m
Yanling Chen
Joint Company Secretary & Executive Director6.3yrsCN¥1.77mデータなし
Wah Kwong Tsang
Independent Non-Executive Director10.8yrsCN¥371.00kデータなし
Xun Zhu
Independent Non-Executive Director10.4yrsCN¥371.00kデータなし
Guan Wang
Independent Non-Executive Director1.3yrsCN¥202.00kデータなし

8.3yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: 460の 取締役会経験豊富 であると考えられます ( 8.3年の平均在任期間)。